Population
Patients with pulmonary arterial hypertension
Design
Review
Authors
Loading...
Emerging PAH therapies may extend survival and QoL; leaves open optimal sequencing and long-term comparative efficacy.
This review discusses recent progress in developing treatments for pulmonary arterial hypertension aimed at prolonging life and improving quality of life.
Humbert et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: